Literature DB >> 4956776

Hydrolysis of synthetic esters by the antibacterial agent in serum.

W W Yotis.   

Abstract

Yotis, William W. (Loyola University, Chicago, Ill.). Hydrolysis of synthetic esters by the antibacterial agent in serum. J. Bacteriol. 91:488-493. 1966.-An antistaphylococcal serum agent was assayed colorimetrically, manometrically, and titrimetrically for esterase activity. p-Nitrophenol acetate, triacetin, l-lysine methyl and ethyl ester, and norleucine methyl ester were hydrolyzed by the antistaphylococcal agent. Acetylcholine and benzoylcholine esters, triolein, tristearin, and p-tosylarginine methyl ester were not attacked by this agent. With p-nitrophenol acetate as substrate, optimal activity occurred at pH 7.4. Incubation at 60 C for 30 min reduced drastically the esterase activity of the antistaphylococcal agent, and incubation at 75 C for 30 min abolished the esterase activity of this agent. Almost complete inhibition of esterase activity was observed with 0.001 m HgCl(2), ZnSO(4), and ethylenediaminetetraacetic acid (EDTA). EDTA inhibition could be reversed by the addition of CaCl(2), but not MgCl(2). Cysteine reversed the inhibition of HgCl(2). NaF, atoxyl, diisopropyl fluorophosphate, quinine, and physostigmine did not influence the esterase activity of the antibacterial agent. The demonstration of esterase activity of both the antistaphylococcal agent and coagulase may shed further light on the reported ability of coagulase to neutralize the antistaphylococcal activity of this agent, or the prevention of absorption of the agent on the staphylococcal cell surface. In addition, the colorimetric procedure described in this report may be a convenient tool in assaying the potency of the antistaphylococcal agent.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4956776      PMCID: PMC314885          DOI: 10.1128/jb.91.2.488-493.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  13 in total

1.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.

Authors:  A L HAINES; I H LEPOW
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  Coagulase in reversing antibacterial activity of normal human serum on Micrococcus pyogenes.

Authors:  R D EKSTEDT; W J NUNGESTER
Journal:  Proc Soc Exp Biol Med       Date:  1955-05

3.  Studies on staphylococci. III. Further studies on purification and mechanism of action of an antibacterial human serum factor.

Authors:  W W YOTIS; R D EKSTEDT
Journal:  J Bacteriol       Date:  1960-11       Impact factor: 3.490

4.  Studies on staphylococci. I. Effect of serum and coagulase on the metabolism of coagulase positive and coagulase negative strains.

Authors:  W W Yotis; R D Ekstedt
Journal:  J Bacteriol       Date:  1959-10       Impact factor: 3.490

5.  The reaction of chymotrypsin and diisopropylphosphorofluoridate. I. Isolation and analysis of diisopropylphosphoryl-peptides.

Authors:  R A OOSTERBAAN; P KUNST; J VAN ROTTERDAM; J A COHEN
Journal:  Biochim Biophys Acta       Date:  1958-03

6.  Assay methods for cholinesterases.

Authors:  K B AUGUSTINSSON
Journal:  Methods Biochem Anal       Date:  1957

7.  The action of thrombin on synthetic substrates.

Authors:  S SHERRY; W TROLL
Journal:  J Biol Chem       Date:  1954-05       Impact factor: 5.157

8.  THE COAGULASE TEST FOR STAPHYLOCOCCI AND ITS CORRELATION WITH THE RESISTANCE OF THE ORGANISMS TO THE BACTERICIDAL ACTION OF HUMAN BLOOD.

Authors:  W W Spink; J J Vivino
Journal:  J Clin Invest       Date:  1942-05       Impact factor: 14.808

9.  Effect of the antibacterial serum factor on staphylococcal infections.

Authors:  W W YOTIS
Journal:  J Bacteriol       Date:  1962-01       Impact factor: 3.490

10.  ABSORPTION OF THE ANTIBACTERIAL SERUM FACTOR BY STAPHYLOCOCCI.

Authors:  W W YOTIS
Journal:  J Bacteriol       Date:  1963-04       Impact factor: 3.490

View more
  1 in total

1.  An assessment of the inhibitory activity of rat serum on staphylococci.

Authors:  W W Yotis; J S Ortiz
Journal:  Antonie Van Leeuwenhoek       Date:  1967       Impact factor: 2.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.